Innovative Partnering Models and Outsourcing Strategies Track at DIA's 49th Annual Meeting

	How do you perform Quality Oversight of CROs - Clinical Vendors?
	What pitfalls are avoidable with strategic partnerships?
	Need to know best practices and latest trends in Regulatory Outsourcing Partnerships?
	Can a "virtual" R&D team model help you access the East Asian pharma market?
	What approaches are needed for transition from transactional to collaboration-based pharma outsourcing?
	How will future of sponsor-CRO partner relations impact the  pharma industry?
	Partnering and outsourcing in India: Strategies for integrating diverse skills around operational deliverables.
	How can Functional Service Providers help pharma industry drive improvement and innovation?
	What are challenges/successes in developing and maintaining Sponsor/ CRO Partnership?
	How can Collaboration make a better Global Trial?
	In what ways can the pharma industry manage risk in outsourced clinical trials?
	What are the Best Practices to Ensuring Strategic Sponsor/ CRO Collaboration Success?
	How does Project Data Sphere clinical trial data-sharing accelerates innovation and enhances patient health?
	Be better prepared to handle change orders in outsourcing. Join this brainstorming forum.
	How will mobile health level the playing field in global health?
	How do FDA collaborations broaden the reach of health care messages to the public?
	Thinking about Nonprofit-Industry Partnership to develop and/or disseminate new technology?

DIA 2013 49th Annual Meeting - Professional Posters Deadline: February 28, 2013

Call for Professional Posters Submit Your Original Research! Professional Posters Deadline: February 28, 2013 Interested in Presenting at the DIA 2013 49th Annual Meeting?  We are now accepting abstracts for the DIA 2013 49th Annual Meeting Professional Poster Session. Professional posters will be presented on:      • Tuesday, June 24 from 11:45AM-4:00PM      • Wednesday, June 26 from 11:45AM-4:00PM Submission Guidelines | Submit Abstract Online Please Note: DIA username and password is needed to submit an abstract. Did you land on the My DIA Page? If so, please select “My Abstract Submissions” on the left side to submit an abstract. Poster submitters are encouraged to submit topics related to one of the DIA 2013 49TH ANNUAL     MEETING TRACKS noted below:      Track 1: Clinical Operations      Track 2: Project/Portfolio Management and Strategic Planning      Track 3: Innovative Partnering Models and Outsourcing Strategies      Track 4: Nonclinical and Translational Development/Early Phase Clinical Development      Track 5: Regulation of Product Advertising and Marketing in an Ever-changing World      Track 6: Medical Communications, Medical Writing and Medical Liaison      Track 7: Processes and Technologies for Clinical Research      Track 8: Regulatory Affairs and Submissions      Track 9: Medical Devices, In Vitro Diagnostics, and Combination Products      Track 10: Public Policy/Health Care Compliance/Law      Track 11: Innovative Approaches to Ensuring Compliance with Good Clinical Practice,                        and Quality Assurance      Track 12: Pharmaceutical Quality      Track 13: Health Economics and Outcomes (HEO )/Comparative Effectiveness Research                        (CER)/Health Technology Assessment (HTA)      Track 14: Clinical Safety and Pharmacovigilance      Track 15: Statistical Science and Quantitative Thinking      Track 16: Professional Development      Track 17: Rare/Orphan Diseases While the theme for 2013 is “Advancing Therapeutic Innovation and Regulatory Science” the following are suggested hot topics for this year’s Professional Poster Program:      • Neuroscience      • Oncology      • Cardiovascular/Metabolic      • Infectious Diseases      • Rare Diseases      • Women’s Health      • Geriatrics • Video Game Treatment for Therapeutic Intervention • Vaccines and Biotech products • Genomics and Personalized Medicine • Interdisciplinary Clinical Research Activities • Clinical Research, Regulatory and Site Operations • Informatics and Biotechnology • Global Clinical Trials           Benefits:      • Designated poster area and poster board to display poster and network with attendees        at the DIA Annual Meeting in Boston      • Accepted abstracts will be posted on the DIA 2013 49th Annual Meeting website      • Electronic version of the poster to be displayed in the DIA 2013 49th Annual Meeting Live        Learning Center      • Abstract title and lead author will be printed in the final program that is distributed to        the Annual Meeting attendees      • NEW THIS YEAR!         Accepted abstracts will be published in an upcoming edition of the Global Forum,         DIA’s digital association news magazine Selected poster presenters are required to pay the applicable meeting registration fee and all related expenses. Questions? Joanne.Wallace@diahome.org

Global Market Access: Essential Knowledge for Clinical Trial Design

DIA 2012 Collaborate to Innovate

48th Annual Meeting
June 24-28, 2012
Philadelphia, PA

Pennsylvania Convention Center

Global Market Access: Essential Knowledge for
Clinical Trial Design
June 24, 8:30AM - 12:00PM

Instructor(s):John Brennick, MPA
Worldwide Market Access
Janssen Global Services, LLC, United States

Description:
Reimbursement approvals from payers (reimbursers) have become as important as regulatory approvals for pharmaceutical product success and providing access to patients. Even with reimbursement approval, payer restrictions such as step edits and individual patient approval significantly impact product usage. This tutorial will provide an overview of global reimbursement systems including health technology assessments (e.g., NICE), and discuss ways in which evidence of value from clinical trials can help or limit market access.

Event	Credit Type	Max Credits	CEU
#23: Global Market Access: Essential Knowledge for	IACET	3.25	0.300

Learning Objectives:
At the conclusion of this tutorial, attendees should be able to:
• Summarize the evidence demands of global payer customers
• Discuss the growing importance of the reimbursement hurdle to patient access to your medicine
• Recognize how aspects of clinical trial design, such as dosing and comparator choice, can impact reimbursement potential

Target Audience:
This tutorial is designed for pharmaceutical industry employees not familiar with market access (pricing, reimbursement, health economics) issues.

for more information...

Clinical Research in the news...

In the News...

Clinical Research

Madison Researchers Making Major Breakthroughs in Stem Cell Work
Stem cells derived from the skin and blood of blind people are morphing into retina-like balls at UW-Madison. Read more...

Northwestern Study Compares Endovascular Brain Aneurysm Repair Devices
Researchers seek to determine if newly FDA-approved gel-coated coils are more effective than the current standard bare platinum coils for aneurysm treatment. Read more...

DIA’s clinical research events provide insight into clinical research best practices across all medical products.

DIA/FDA Oligonucleotide-based Therapeutics 2012
April 16-18 | Washington, DC

Using Pharmacokinetic and Pharmacodynamic Principles to Enable IND and NDA Submissions
April 16-17 | Bethesda, MD

Creating a Global Clinical Trial Platform for the Protection of Human Subjects
May 15 | Durham, NC